Literature DB >> 25299607

Acute neurologic illness of unknown etiology in children - Colorado, August-September 2014.

Daniel M Pastula, Negar Aliabadi, Amber K Haynes, Kevin Messacar, Teri Schreiner, John Maloney, Samuel R Dominguez, Emily Spence Davizon, Eyal Leshem, Marc Fischer, W Allan Nix, M Steven Oberste, Jane Seward, Daniel Feikin, Lisa Miller.   

Abstract

On September 12, 2014, CDC was notified by the Colorado Department of Public Health and Environment of a cluster of nine children evaluated at Children's Hospital Colorado with acute neurologic illness characterized by extremity weakness, cranial nerve dysfunction (e.g., diplopia, facial droop, dysphagia, or dysarthria), or both. Neurologic illness onsets occurred during August 8-September 15, 2014. The median age of the children was 8 years (range = 1-18 years). Other than neck, back, or extremity pain in some patients, all had normal sensation. All had a preceding febrile illness, most with upper respiratory symptoms, occurring 3-16 days (median = 7 days) before onset of neurologic illness. Seven of eight patients with magnetic resonance imaging of the spinal cord had nonenhancing lesions of the gray matter of the spinal cord spanning multiple levels, and seven of nine with magnetic resonance imaging of the brain had nonenhancing brainstem lesions (most commonly the dorsal pons). Two of five with magnetic resonance imaging of the lumbosacral region had gadolinium enhancement of the ventral nerve roots of the cauda equina. Eight children were up to date on polio vaccination. Eight have not yet fully recovered neurologically.

Entities:  

Mesh:

Year:  2014        PMID: 25299607      PMCID: PMC4584613     

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


On September 12, 2014, CDC was notified by the Colorado Department of Public Health and Environment of a cluster of nine children evaluated at Children’s Hospital Colorado with acute neurologic illness characterized by extremity weakness, cranial nerve dysfunction (e.g., diplopia, facial droop, dysphagia, or dysarthria), or both. Neurologic illness onsets occurred during August 8–September 15, 2014. The median age of the children was 8 years (range = 1–18 years). Other than neck, back, or extremity pain in some patients, all had normal sensation. All had a preceding febrile illness, most with upper respiratory symptoms, occurring 3–16 days (median = 7 days) before onset of neurologic illness. Seven of eight patients with magnetic resonance imaging of the spinal cord had nonenhancing lesions of the gray matter of the spinal cord spanning multiple levels, and seven of nine with magnetic resonance imaging of the brain had nonenhancing brainstem lesions (most commonly the dorsal pons). Two of five with magnetic resonance imaging of the lumbosacral region had gadolinium enhancement of the ventral nerve roots of the cauda equina. Eight children were up to date on polio vaccination. Eight have not yet fully recovered neurologically. Eight patients demonstrated a mild to moderate cerebrospinal fluid (CSF) pleocytosis (>5 white blood cells/μL), predominantly lymphocytic, consistent with an inflammatory or infectious process. CSF glucose was normal; CSF protein was normal or mildly elevated. Initial testing of CSF from eight patients showed no evidence of West Nile virus antibodies, although further testing is pending. CSF testing for enteroviruses, including enterovirus D68 (EV-D68), enterovirus 71, and poliovirus, by reverse transcription–polymerase chain reaction (RT-PCR) was negative in all patients. Other CSF tests for infectious causes were unrevealing. Initial nasopharyngeal specimens were available for eight children. Six were positive for rhinovirus/enterovirus by RT-PCR. These six positive nasopharyngeal specimens were subsequently typed: four were identified as EV-D68, one as rhinovirus A24, and one was not EV-D68 but has not been typed further. The specimen positive for rhinovirus A24 also was positive for adenovirus by RT-PCR. Single rectal swabs or stool samples from eight patients were negative for enterovirus (including poliovirus) by RT-PCR. This cluster of acute neurologic illnesses occurred against a backdrop of detection of EV-D68 causing severe respiratory disease in many parts of the United States, including Colorado (1,2). There are two case reports in the literature of EV-D68 causing neurologic illness (acute flaccid paralysis and encephalomyelitis) as evidenced by detection of EV-D68 in the CSF (3,4). However, given the current suspected widespread circulation of EV-D68 respiratory infections in Colorado, and the antecedent respiratory illness in most of these children, the detection of EV-D68 in nonsterile upper respiratory tract specimens in those with neurologic illness might be coincidental. Epidemiologic and laboratory investigations of these cases are ongoing. On September 19, the Colorado Department of Public Health and Environment issued a Health Alert informing Colorado clinicians of this cluster and requesting reports of similar cases. One additional case with similar neurologic findings was reported as a result of this advisory and is currently under investigation. On September 26, CDC issued a national Health Advisory (available at http://www.bt.cdc.gov/han/han00370.asp ), which provides guidance for identifying and reporting cases. Clinicians should report to their local and state health departments patients aged ≤21 years with 1) acute onset of focal limb weakness occurring on or after August 1, 2014, and 2) magnetic resonance imaging showing a spinal cord lesion largely restricted to gray matter. To prevent infections in general, persons should stay home if they are ill, wash their hands often with soap and water, avoid close contact (such as touching and shaking hands) with those who are ill, and clean and disinfect frequently touched surfaces.
  2 in total

1.  A fatal central nervous system enterovirus 68 infection.

Authors:  Justin D Kreuter; Arti Barnes; James E McCarthy; Joseph D Schwartzman; M Steven Oberste; C Harker Rhodes; John F Modlin; Peter F Wright
Journal:  Arch Pathol Lab Med       Date:  2011-06       Impact factor: 5.534

2.  Severe respiratory illness associated with enterovirus D68 - Missouri and Illinois, 2014.

Authors:  Claire M Midgley; Mary Anne Jackson; Rangaraj Selvarangan; George Turabelidze; Emily Obringer; Daniel Johnson; B Louise Giles; Ajanta Patel; Fredrick Echols; M Steven Oberste; W Allan Nix; John T Watson; Susan I Gerber
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-09-12       Impact factor: 17.586

  2 in total
  43 in total

1.  Discovery of Structurally Diverse Small-Molecule Compounds with Broad Antiviral Activity against Enteroviruses.

Authors:  Jun Zuo; Steve Kye; Kevin K Quinn; Paige Cooper; Robert Damoiseaux; Paul Krogstad
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

2.  A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-14): a retrospective cohort study.

Authors:  Alexander L Greninger; Samia N Naccache; Kevin Messacar; Anna Clayton; Guixia Yu; Sneha Somasekar; Scot Federman; Doug Stryke; Christopher Anderson; Shigeo Yagi; Sharon Messenger; Debra Wadford; Dongxiang Xia; James P Watt; Keith Van Haren; Samuel R Dominguez; Carol Glaser; Grace Aldrovandi; Charles Y Chiu
Journal:  Lancet Infect Dis       Date:  2015-03-31       Impact factor: 25.071

3.  Enterovirus infections in Singaporean children: an assessment of neurological manifestations and clinical outcomes.

Authors:  Wen Yi Thong; Audrey Han; S J Furene Wang; Jeremy Lin; Mas Suhaila Isa; Evelyn Siew Chuan Koay; Stacey Kiat-Hong Tay
Journal:  Singapore Med J       Date:  2016-06-01       Impact factor: 1.858

Review 4.  Viral diseases of the central nervous system.

Authors:  Phillip A Swanson; Dorian B McGavern
Journal:  Curr Opin Virol       Date:  2015-02-12       Impact factor: 7.090

5.  Adult case of acute flaccid paralysis with enterovirus D68 detected in the CSF.

Authors:  Keishi Kimura; Takao Fukushima; Naoko Katada; Hiroyuki Shimizu; Tomofumi Nakamura; Tsuguto Fujimoto; Nozomu Hanaoka; Keiko Tanaka-Taya; Kunihiko Makino
Journal:  Neurol Clin Pract       Date:  2017-10

6.  The polio eradication endgame: Why immunization and continued surveillance is critical.

Authors:  T F Booth; E Grudeski; A McDermid; J Rotondo
Journal:  Can Commun Dis Rep       Date:  2015-10-01

7.  MRI findings in children with acute flaccid paralysis and cranial nerve dysfunction occurring during the 2014 enterovirus D68 outbreak.

Authors:  J A Maloney; D M Mirsky; K Messacar; S R Dominguez; T Schreiner; N V Stence
Journal:  AJNR Am J Neuroradiol       Date:  2014-11-20       Impact factor: 3.825

Review 8.  Acute flaccid myelitis: A clinical review of US cases 2012-2015.

Authors:  Kevin Messacar; Teri L Schreiner; Keith Van Haren; Michele Yang; Carol A Glaser; Kenneth L Tyler; Samuel R Dominguez
Journal:  Ann Neurol       Date:  2016-08-04       Impact factor: 10.422

9.  National surveillance for non-polio enteroviruses in Canada: Why is it important?

Authors:  T F Booth; E Grudeski; A McDermid
Journal:  Can Commun Dis Rep       Date:  2015-02-20

10.  Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68-Associated Paralytic Myelitis.

Authors:  Alison M Hixon; Penny Clarke; Kenneth L Tyler
Journal:  J Infect Dis       Date:  2017-12-05       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.